BRUSSELS (Reuters) – The European Commission will authorise on Tuesday a deal with biotech firm CureVac to secure up to 405 million doses of its potential COVID-19 vaccine, the head of the European Commission Ursula von der Leyen said on Monday.
The Commission president also said she hopes to finalise a deal soon with Moderna for its COVID-19 vaccine.
(Reporting by Francesco Guarascio @fraguarascio)
